# FDA Inspection 1276292 - Paul Schulz, M.D. - July 22, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/paul-schulz-md/701d1a8e-9863-4ed7-abae-fbbd380a3eaa
Source feed: FDA_Inspections

> FDA Inspection 1276292 for Paul Schulz, M.D. on July 22, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276292
- Company Name: Paul Schulz, M.D.
- Inspection Date: 2025-07-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1276292 - 2025-07-22](https://www.globalkeysolutions.net/records/fda_inspections/paul-schulz-md/932de77b-77bc-49b7-a788-1a25bc11f525)

Company: https://www.globalkeysolutions.net/companies/paul-schulz-md/9385b561-5e91-41ad-abbc-f954ae6f436c

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9